Integrated BioPharma, Inc.
INBP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $14 | $14 | $13 |
| % Growth | -100% | 1.6% | 10.6% | – |
| Cost of Goods Sold | $0 | $13 | $12 | $11 |
| Gross Profit | $1 | $1 | $2 | $1 |
| % Margin | – | 10.4% | 11.1% | 9.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $1 | $1 | $0 |
| % Margin | – | 4.2% | 5.3% | 1.6% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | $0 | $1 | $1 | $0 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | $0 | -$0 | $1 | $0 |
| % Margin | – | -1.3% | 4.4% | 0.9% |
| EPS | 0.004 | -0.006 | 0.02 | 0.004 |
| % Growth | 169% | -128.7% | 431.6% | – |
| EPS Diluted | 0.004 | -0.006 | 0.019 | 0.004 |
| Weighted Avg Shares Out | 31 | 31 | 30 | 30 |
| Weighted Avg Shares Out Dil | 31 | 31 | 32 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | – | 6.5% | 7.5% | 4.1% |